公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1 | Ohashi K; Sequist L.V; Arcila M.E; Moran T; Chmielecki J; Lin Y.-L; Pan Y; Wang L; De Stanchina E; Shien K; Aoe K; Toyooka S; Kiura K; Fernandez-Cuesta L; Fidias P; CHIH-HSIN YANG ; Miller V.A; Riely G.J; Kris M.G; Engelman J.A; Vnencak-Jones C.L; Dias-Santagata D; Ladanyi M; Pao W. | Proceedings of the National Academy of Sciences of the United States of America | 389 | 366 | |
2007 | MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib | Bean J.; Brennan C.; JIN-YUAN SHIH ; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; CHONG-JEN YU ; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; PAN-CHYR YANG ; Miller V.; Ladanyi M.; CHIH-HSIN YANG ; Pao W. | Proceedings of the National Academy of Sciences of the United States of America | 1513 | 1379 | |
2016 | Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women | Wang Z.; Seow W.-J.; Shiraishi K.; Hsiung C.A.; Matsuo K.; Liu J.; Chen K.; Yamji T.; Yang Y.; Chang I.-S.; Wu C.; Ho J.C.M.; Chan J.K.C.; Wang J.-C.; Lu D.; Zhao X.; Zhao Z.; Wu J.; Chen H.; Jin L.; Wei F.; Hong Y.-C.; Wu G.; An S.-J.; Zhang X.-C.; Su J.; Wu Y.-L.; Gao Y.-T.; Xiang Y.-B.; He X.; Li J.; Zheng W.; Burdett L.; Shu X.-O.; Cai Q.; Klein R.; Pao W.; Lawrence C.; Hosgood H.D.; III, Hsiao C.-F.; Chien L.-H.; Chen Y.-H.; Chen C.-H.; Wyatt K.; Wang W.-C.; Chen C.-Y.; Wang C.-L.; CHONG-JEN YU ; Chen H.-L.; Su Y.-C.; Tsai F.-Y.; Chen Y.-S.; Li Y.-J.; Yang T.-Y.; Chung C.C.; Lin C.-C.; PAN-CHYR YANG ; Wu T.; Lin D.; Zhou B.; Yu J.; Shen H.; Kubo M.; Chanock S.J.; Rothman N.; Li S.A.; Lan Q.; Yeager M.; Hutchinson A.; Hu W.; Caporaso N.; Landi M.T.; Chatterjee N.; Song M.; Fraumeni J.F.; Jr.; Kohno T.; Yokota J.; Kunitoh H.; Ashikawa K.; Momozawa Y.; Daigo Y.; Mitsudomi T.; Yatabe Y.; Hida T.; Hu Z.; Dai J.; Ma H.; Jin G.; Song B.; Wang Z.; Cheng S.; Yin Z.; Li X.; Ren Y.; Guan P.; Chang J.; Tan W.; Chen C.-J.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; KUAN-YU CHEN ; Huang M.-S.; Chen Y.-M.; Zheng H.; Li H.; Cui P.; Guo H.; Xu P.; Liu L.; Iwasaki M.; Shimazu T.; Tsugane S.; Zhu J.; Jiang G.; Fei K.; Park J.Y.; Kim Y.H.; Sung J.S.; Park K.H.; Kim Y.T.; Jung Y.J.; Kang C.H.; Park I.K.; Kim H.N.; Jeon H.-S.; Choi J.E.; Choi Y.Y.; Kim J.H.; Oh I.-J.; Kim Y.-C.; Sung S.W.; Kim J.S.; Yoon H.-I.; Kweon S.-S.; Shin M.-H.; Seow A.; Chen Y.; Lim W.-Y.; Liu J.; Wong M.P.; Lee V.H.F.; Bassig B.A.; Tucker M.; Berndt S.I.; Chow W.-H.; Ji B.-T.; Wang J.; Xu J.; Sihoe A.D.L. | Human Molecular Genetics | 43 | 34 | |
2012 | Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma | Girard N; Sima C.S; Jackman D.M; Sequist L.V; Chen H; CHIH-HSIN YANG ; Ji H; Waltman B; Rosell R; Taron M; Zakowski M.F; Ladanyi M; Riely G; Pao W. | European Respiratory Journal | 77 | 90 | |
2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy | CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN ; ZHONG-ZHE LIN ; Huang C.-J.; CHIA-TUNG SHUN ; Huang C.-L.; Bean J.; ANN-LII CHENG ; Pao W.; PAN-CHYR YANG | Journal of Clinical Oncology | 240 | 224 | |